Methotrexate 25 mg/mL
Methotrexate · INJECTION, SOLUTION · Teva Parenteral Medicines, Inc.
No Recall History
Plain English
Methotrexate is a injection, solution containing methotrexate at 25 mg/mL, taken intra-arterial. Manufactured by Teva Parenteral Medicines, Inc..
Key Facts
- Brand Name
- Methotrexate
- Generic Name
- Methotrexate
- NDC Code (Product)
0703-3675- Manufacturer
- Teva Parenteral Medicines, Inc.
- Strength
- 25 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRA-ARTERIAL, INTRAMUSCULAR, INTRATHECAL, INTRAVENOUS
- Marketing Status
- Application #
- ANDA040843
- Marketing Start
- 08/01/2012
Recall History
No Recall HistoryFrequently Asked Questions
What is Methotrexate used for?
Methotrexate contains Methotrexate. It is a injection, solution taken intra-arterial. Consult your doctor for specific uses.
Is Methotrexate a controlled substance?
Methotrexate is not classified as a controlled substance by the DEA.
What is the generic name for Methotrexate?
The generic name for Methotrexate is Methotrexate. There are 6 other brand versions of Methotrexate.
What is the NDC code for Methotrexate 25 mg/mL?
The NDC (National Drug Code) for Methotrexate 25 mg/mL is 0703-3675, listed by Teva Parenteral Medicines, Inc..